Bioinformatics Market Size, Share, Growth, and Industry Analysis, By Type (Knowledge Management Tools and Data Analysis Platforms), By Application (Genomics, Chemoinformatic and Drug Design, Proteomics, Transcriptomics, Metabolomics and Others), and Regional Forecast to 2034

• 

  Request a Free sample to learn more about this report

BIOINFORMATICS MARKET OVERVIEW

The bioinformatics market value at USD 11.4 billion in 2025, and reaching USD 35.01 billion by 2034, expanding at a CAGR of 13.27% from 2025 to 2034.

The United States Bioinformatics market size is projected at USD 5.05 billion in 2025, the Europe Bioinformatics market size is projected at USD 2.55 billion in 2025, and the China Bioinformatics market size is projected at USD 1.28 billion in 2025.

Bioinformatics market is witnessing high growth, due to increase in genomics, big data analytics and artificial intelligence (AI) in life sciences. This converts complex biological information to understandable computational phrases, which is in which bioinformatics steps in The rising application of next-generation sequencing (NGS), proteomics and data analysis by AI which is ramping up the imperative for bioinformatics applications in biotech as well as pharma & academia.

Given the rise of precision medicine, cloud bioinformatics platforms and burgeoning CRISPR genome editing tools across the industry a data driven approach to decision making in healthcare as well life sciences go forward. Investments in bioinformatics software, database and analytical tools are increasing rapidly by government as well private organizations for cancer research supporting efforts, infectious disease studies and agricultural biotechnology. Since the exponential growth of biological data is increasing, bioinformatics market is going to evolve with incorporation advanced-AI applications, ML and cloud computing in data management to allow more efficient discoveries & enable healthcare innovations.

KEY FINDINGS

COVID-19 IMPACT 

Bioinformatics Industry Had a Positive Effect Due to accelerated adoption of data-driven healthcare solutions during COVID-19 Pandemic

The global COVID-19 pandemic has been unprecedented and staggering, with the market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden market growth reflected by the rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

COVID-19 pandemic has profound impact on the bioinformatics market by catalyzing adoption of data-driven health solutions, genomic research and AI driven analytics. The pressing need for virus genome sequencing, vaccine development and drug discovery spurred new investments in bioinformatics in-house assets, as well as cloud platforms that could process large biological data sets. Bioinformatics and cloud platforms were used in governments, pharma and research institutions investigate virus mutations, diagnostic development, treatment regimens Government bioinformatics related insights drives approval for precision medicines and personalized healthcare thus increasing need from genomics proteomics to biomarker research Further, as big data, AI and high-performance computing go mainstream in life sciences the bioinformatics market is expected to grow steadily helping disease therapeutics research and expedite new drug discoveries, next-generation sequencing etc.

LATEST TRENDS

AI, Cloud Computing, and Genomic Innovations to Drive Market Growth

The bioinformatics market is seeing a major development in the form of AI/ML/cloud being used to drive capabilities and delivery biological data analysis faster in research. Next-Generation AI bioinformatics pipelines are allowing researchers to efficiently process large genomic datasets and, as such, augment drug discovery insights in disease diagnostics and personalized medicine. Moreover, recent development in cloud bioinformatics resources are opening way for all global researchers and pharma companies to store, share data and work in real time. Another recent trend is the diversification of bioinformatics into agriculture and environmental sciences, where genomic analysis is being used to build more resilient crops, optimize breeding and soil sustainability. There is increasing interest in using blockchain as a means for secure biological data sharing (data integrity and privacy verification in genomics), we have observed. Fueled by demand for precision bio-medicine, genome sequencing and innovation in life sciences with a push towards bioinformatics is a major driver as well the next few years.

• According to the U.S. National Center for Biotechnology Information (NCBI), over 35 million genomic sequences were submitted to public databases in 2023, reflecting the rapid growth of bioinformatics applications in genomics.
• According to the European Bioinformatics Institute (EBI), more than 70% of newly established bioinformatics labs have adopted cloud computing solutions for data analysis in the past 2 years.

Request a Free sample to learn more about this report

BIOINFORMATICS MARKET SEGMENTATION

By Type

Based on type, the global market can be categorized into knowledge management tools and data analysis platforms

• Knowledge Management Tools – Software and databases for managing, curating, archiving biological dates. Software databases to store, organize & retrieve biological information easily. These tools are required to handle data exhaust of genomics, proteomics and drug discovery for the big datasets.
• Data Analysis Platforms – Advanced computational platforms that process, analyze, and interpret biological data using algorithms, machine learning, and AI-driven analytics. These platforms enable researchers to derive meaningful insights for applications such as precision medicine and biomarker discovery.

By Application

Based on application, the global market can be categorized into genomics, cheminformatics and drug design, proteomics, transcriptomics, metabolomics and others

• Genomics – Bioinformatics tools that facilitate sequence analysis, detection of genetic variations and computational supports for genome mapping have relevance in disease research and personalized medicine
• Cheminformatics and Drug Design – Computational approaches to molecular modeling, drug-target interaction studies, and virtual screening, in order to speed up a drug discovery paradigm.
• Proteomics – The bioinformatics support the analysis of protein structures and networks, which drives progress in biomarker discovery and diagnostic aids.
• Transcriptomics – The analysis of RNA- sequencing and gene expression data to investigate gene regulation in response to treatments, cellular responses etc.
• Metabolomics – Concerned with the study and analysis of metabolic pathways and biochemical compounds in living organisms, hopefully diagnostics of disease and targets for therapeutics.
• Others – Comprises applications in bioinformatic therefore agriculture, microbiology and environmental studies such as microbial genomes analysis and genetically engineered crops.

MARKET DYNAMICS

Market dynamics include driving and restraining factors, opportunities and challenges stating the market conditions.

Driving Factor

Growing Demand for Precision Medicine and Genomic Research to Boost the Market

Precise medicine and genomic advances represent a few of the factors driving the bioinformatics market growth. Bioinformatics services offer researchers a way to handle and understand large amounts of genomic data, to track down certain genetic alterations associated with disease and eventually develop targeted therapies. Bioinformatics is fundamental for NGS technologies that are at the heart of next-generation sequencing (NGS), which enables it to process and interpret the complex genetic information for personalized medicine (single-cell analysis), cancer diagnostics or rare diseases research. Government initiatives and funding to genomic pursuits such as the Human Genome Project, as well national precision medicine programs furthering accelerating of bioinformatics solutions.

• According to the National Institutes of Health (NIH), around 15,000 clinical trials involving genomic testing are ongoing globally, driving the need for bioinformatics tools to interpret complex data.
• According to the Human Proteome Organization (HUPO), over 10,000 new protein structures were identified in 2022, increasing reliance on bioinformatics platforms for functional annotation.

Rising Integration of AI and Big Data in Life Sciences to Expand the Market

Bioinformatics market is growing faster with rapid AI and big data analytics integration into the biological research global arena. AI bioinformatics platforms enable faster data processing, better predictive modeling and full automation of complex analyses in genomics, proteomics from discovery time to design to manufacture the drug. Moreover, big data technologies enable to store these big biological datasets coming out of sequencing, clinical trails and biomedical research. Market is further developed with the increasing demand for solutions enabled by AI & machine learning driving by necessity of data driven decision making among life sciences companies/research institutes.

Restraining Factor

High Cost and Complexity of Bioinformatics Software and Infrastructure to Potentially Impede Market Growth

One of the important restrains on market growth in bioinformatics is expensive and complicated bioinformatics software, hardware, data storage infrastructure. The more sophisticated the bioinformatics platforms are, they need substantial inputs in regards computational resources, cloud storage and high-performance computing (HPC) systems to manage large biological data sets. Further complicating the matter, integrating bioinformatics through existing laboratory and clinical workflows can be complicated to establish and heavily depends on specialized expertise as well as technical training. Small research institutions and even biotech startups face financial and operational hurdles as well, to adopt to bioinformatics solutions which make this market has a short runway.

• According to the U.S. Department of Health & Human Services (HHS), 43% of healthcare organizations reported challenges in sharing patient genomic data due to privacy regulations.
• According to the European Commission’s report on digital health, nearly 60% of small laboratories face difficulties in adopting advanced bioinformatics software due to lack of expertise.

 Expansion of Cloud-Based Bioinformatics Solutions To Create Opportunity for the Product in the Market

Opportunity

Growth opportunities in bioinformatics market could be primarily driven by the rising cloud adoption of bioinformatics solutions. Cloud computing is an appropriate, flexible and cost-effective solution for running large biological datasets processing platforms in a big way at scale with no need to capitalize infrastructure upfront. The cloud Bioinformatics tools allow real-time data sharing, give researchers collaborative environment to work together and combine with AI analytics that make genome research development, drug discovery and personalized medicine real-time. With the growing need from pharma companies, research institutions and healthcare providers for flexible scalable data management solutions, thereby an increase in development and expansion of innovation due to demand cloud bioinformatics platforms.

• According to the U.S. Food and Drug Administration (FDA), over 120 AI-driven bioinformatics tools have been approved for clinical research purposes since 2020.
• According to the World Health Organization (WHO), bioinformatics research facilities increased by 25% in Asia and Africa between 2021–2023, creating new market opportunities.

Data Security and Privacy Concerns in Bioinformatics Could Be a Potential Challenge for Consumers

Challenge

A key hindrance to bioinformatics market development is its challenges of data security maintaining strict privacy regulations at major scale. Sensitive genetic and patients data ( yotta bytes worth) gives bioinformatics platforms the ability to be quite juicy and a magnet for cyber threats, data breaches, unauthorized request. The regulatory frameworks like GDPR (General Data Protection Regulation) and HIPAA (Health Insurance Portability and Accountability Act) have very stringent regulations around how one data is stored, shared or even kept secret which further complicates bioinformatics database management. Storing the data securely in the cloud, data transfer encryption and staying up-to-date with changing regulations — is a hard and big issue for bioinformatics companies as well as the research institutions.

• According to the Global Alliance for Genomics and Health (GA4GH), over 50% of genomic datasets are incompatible with standard analysis pipelines, limiting interoperability.
• According to the National Science Foundation (NSF), initial setup of bioinformatics infrastructure for medium-sized labs can exceed $500,000, posing a financial barrier.

• Request a Free sample to learn more about this report

•  

BIOINFORMATICS MARKET REGIONAL INSIGHTS

• North America

North America dominates the global market for bioinformatics, owing to progress in genomic research, advancement of personalized medicine and data analytics. This expansion of AI and cloud computing within bioinformatics tools supported by sizeable investments in biotechnology as well as pharmaceutical industries is an important driver for this market. Likewise, the region has a robust healthcare infrastructure and government initiatives that support genomics research, drug discovery capabilities, as well as data-driven healthcare solutions. The United States bioinformatics market is the first to innovate, led by premier research institutions support, heavy government funding and collaboration between biotech companies and university centers. The strong emphasis on precision medicine, drug discovery and genomic data sequencing in the country accounts for a large share of bioinformatics market and hence, it is one among the world leaders of this segment. Advent of next-generation sequencing (NGS) technologies and growing need for bioinformatics software and platforms in the U.S. is fueling further growth of market.

• Europe

In Europe, the bioinformatics market share is increasing following rising investments into biomedical research, bioinformatics infrastructure, and health IT digitization. Nations such as Germany, British and France are significant drivers using bioinformatics for genomics, clinical research, biopharmaceuticals as well. Expansion in Market Opportunities Bioinformatics is becoming more and more commonly applied to agriculture, environmental studies and synthetic biology. Moreover, the advanced data privacy and ethical research practice of European Union regulatory frameworks have been boosting trust & adoption of bioinformatics solutions in multiple domains.

• Asia

Asia bioinformatics market is witnessing exponential growth due support from the government for biotech research and development, growing pharmaceutical industries and increasing cases of precision medicine. Just like in next-generation sequencing (NGS), artificial intelligence-driven bioinformatics platforms and cloud capabilities countries are developing now being invested by China, India and Japan. The booming contract research industry in the Asia along with affordable bioinformatics services is therefore luring foreign companies to engage with domestic firms. With a strong focus on cost-effective bioinformatics solutions the region caters for substantial market growth on and further consolidating the market share of bioinformatics in global.

KEY INDUSTRY PLAYERS

Key Industry Players Shaping the Market Through Innovation and Market Expansion

Key players in the bioinformatics market are focusing on technological advancements, strategic collaborations, and expanding their service offerings to enhance their market presence. Companies are integrating AI, machine learning, and cloud computing into bioinformatics tools to improve genomic analysis, drug discovery, and precision medicine applications. Many firms are partnering with biotech and pharmaceutical companies to accelerate research in next-generation sequencing (NGS), biomarker identification, and personalized medicine. Additionally, leading players are expanding their bioinformatics software portfolios and investing in data security solutions to comply with stringent regulatory requirements. These efforts contribute to the increasing bioinformatics market share by ensuring efficient data management and accelerating biomedical research.

• Genoox: According to the company’s press release, Genoox’s cloud platform processed over 2 million genomic variants in 2023 for clinical interpretation.
• Seven Bridges Genomics: According to Seven Bridges’ annual report, its platform supported over 400 large-scale collaborative projects in genomics research globally in 2023.

List of Top Bioinformatics Companies

• Genoox
• Seven Bridges Genomics
• BGI
• Genedata
• Interpace Diagnostics
• QIAGEN
• Thermo Fisher Scientific
• Fabric Genomics
• Genomatrix (Intrexon)
• Agilent Technologies
• Codexis
• Biomax Informatics AG
• Tempus
• Eurofins Scientific
• Illumina
• DNAnexus
• Wuxi NextCODE
• Oxford Gene Technology

KEY INDUSTRY DEVELOPMENT

March 2023: Illumina Inc. (United States) launched an AI-powered bioinformatics platform to enhance genomic data analysis for researchers and healthcare providers. The new platform integrates machine learning algorithms to improve the accuracy and speed of next-generation sequencing (NGS) data interpretation, accelerating advancements in precision medicine and drug discovery. This development strengthens Illumina’s position in the bioinformatics market share, reinforcing its commitment to advancing genomic research and providing scalable bioinformatics solutions to pharmaceutical and healthcare industries globally.

REPORT COVERAGE

The bioinformatics market report provides an in-depth analysis of market trends, key drivers, challenges, and opportunities influencing the industry's growth. It examines the increasing adoption of bioinformatics tools in genomics, drug discovery, and precision medicine, highlighting the role of AI, cloud computing, and big data analytics in enhancing research capabilities. The report also explores the rising demand for next-generation sequencing (NGS) data interpretation, biomarker identification, and personalized medicine, which are driving investments in bioinformatics software and services. Additionally, it evaluates the impact of government initiatives, regulatory policies, and collaborations between biotech firms, research institutions, and healthcare providers in shaping market dynamics.

Furthermore, the report provides a comprehensive competitive landscape, profiling major bioinformatics companies and their strategic initiatives, including technological advancements, mergers and acquisitions, and global expansions. It assesses regional market performance, with a focus on North America, Europe, and Asia, detailing factors influencing their bioinformatics market share. The study also includes insights into emerging trends, such as the integration of blockchain technology for secure data sharing, and the increasing role of bioinformatics in agriculture, environmental research, and synthetic biology. With detailed segmentation by application, technology, and end-user industries, the report serves as a valuable resource for stakeholders looking to capitalize on market opportunities.